NCI 微生物癌症治疗会议报告。

Report on the NCI Microbial-Based Cancer Therapy Conference.

机构信息

Critical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland.

Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.

出版信息

Cancer Immunol Res. 2018 Feb;6(2):122-126. doi: 10.1158/2326-6066.CIR-17-0748.

DOI:10.1158/2326-6066.CIR-17-0748

PMID:29437145

Abstract

The National Cancer Institute Inaugural Microbial-Based Cancer Therapy Conference was held in Bethesda, Maryland, on July 11-12, 2017. This interdisciplinary forum included industry leaders, academic investigators, and regulatory officers involved in the development of microbial-based therapies for the treatment of cancer. The aim of the meeting was to discuss the potential of virus- and bacteria-based therapies to halt tumorigenesis and induce immune responses in cancers where conventional therapy is inadequate. This summary highlights topics and viewpoints raised by the presenters and discussants and should not be viewed as the conclusions or recommendations of the workshop as a whole. .

摘要

美国国家癌症研究所首届基于微生物的癌症治疗会议于 2017 年 7 月 11 日至 12 日在马里兰州贝塞斯达举行。这个跨学科的论坛包括了参与开发用于癌症治疗的基于微生物的疗法的行业领导者、学术研究人员和监管人员。会议的目的是讨论病毒和细菌疗法在常规疗法不足的癌症中阻止肿瘤发生和诱导免疫反应的潜力。本摘要突出了演讲者和讨论者提出的主题和观点，不应被视为整个研讨会的结论或建议。